chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Experienced significant increase in pre-existing tinnitus in right ear, and new onset of tinnitus and possible sudden hearing loss in left ear following vaccination; Experienced significant increase in pre-existing tinnitus in right ear, and new onset of tinnitus and possible sudden hearing loss in left ear following vaccination; This is a spontaneous report from a contactable consumer (patient). A 43-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration, administered in arm left on 03Apr2021 10:30 (Batch/Lot Number: ED7533) as single dose for covid-19 immunisation. Medical history included AV block, colitis, optic neuritis, previous hearing loss in right ears and pre-existing tinnitus in right ears all from an unknown date and unknown if ongoing. Concomitant medications included montelukast; clarithromycin (CLARITIN) and bisacodyl (DULCOLAX); all taken for an unspecified indication, start and stop date were not reported. The patient previously took amoxicillin and vancomycin and experienced allergies. The patient experienced experienced significant increase in pre-existing tinnitus in right ear, and new onset of tinnitus and possible sudden hearing loss in left ear following vaccination on 03Apr2021 13:00. Contacting doctor, the patient was hesitant to receive second vaccination. No treatment was received for the events. The patient did not recover from the events.
4/15 Community Covid Vaccine Clinic-1st dose of Moderna Covid Vaccine was given on right arm, RN noticed vaccine leakage and dripping of vaccine. Rn made decision to give 2dn dose of Moderna vaccine.
Body aches; Chills; Feverish / did not have a fever; Shaking; Headache / continues to get worse; This case was reported by a consumer via call center representative and described the occurrence of general body pain in a 54-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 5th January 2021, the patient received the 1st dose of Shingrix (intramuscular). In January 2021, 5 hrs after receiving Shingrix, the patient experienced general body pain, chills, hot feeling generalized, tremor and headache. On an unknown date, the outcome of the general body pain, chills, hot feeling generalized, tremor and headache were unknown.   It was unknown if the reporter considered the general body pain, chills, hot feeling generalized, tremor and headache to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in left arm and approximately five hours later, she started having body aches. The patient woke up at night feeling chills, feverish and shaking. The patient did not have a fever. The patient reported that she experienced headache less than a day, which continued to get worse. The reporter did not consent to follow up.
Tachycardia, chest pressure,nausea,vomiting x 24 hours,pain  to entire body, irregular menses.
Developed shingles lesions on face and under left eye lid on 1/8/2015.
5/24/12 patient received ZOSTAVAX vaccine 5/26/12 - patient presents with minimal pain, superficial swelling, pinpoint cuts at injection site. No other symptoms other than these local reactions.
Patient presented to the pharmacy consultation window with a rash across her lower back. She wanted to know what to do for treatment options to help with the itchiness. I asked if she was having a hard time breathing and she said she was not really having a issue with her breathing just the rash. I told her to take some BENADRYL and that she could put hydro-cortisone on it. She asked if she needed to get the next one in the series and I said the benefits probably outweigh the risks for the future immunizations and that she would only be getting 1 shot on each of the next series in different months since she had gotten both the Hep A and B vaccines on this last visit. I told her to look out for difficulty breathing and if this were to occur to seek medical treatment from the ER. She thanked me and got the OTC items.
pricking, zap/jab feeling starts in primarily the bilateral feet and ankles neuropathy; stabbing pain across lower back-area of sacrum, across upper back-area between the shoulders, bilateral feet, ankles, hands & ear dum area; stabbing pain across lower back-area of sacrum, across upper back-area between the shoulders, bilateral feet, ankles, hands & ear dum area; stabbing pain across lower back-area of sacrum, across upper back-area between the shoulders, bilateral feet, ankles, hands & ear dum area; stabbing pain across lower back-area of sacrum, across upper back-area between the shoulders, bilateral feet, ankles, hands & ear dum area; stabbing pain across lower back-area of sacrum, across upper back-area between the shoulders, bilateral feet, ankles, hands & ear dum area; the amount of sleep had decreased to no sleep; dose number: 3; This is a spontaneous report from a contactable consumer. This 64-year-old female consumer (patient) reported for herself that she received 3rd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot FC3181) single dose on 11Oct2021 at 11:00 AM at right arm for COVID-19 immunization at the age of 64 years old. Medical history included history of mild Asthma, allergies: Penicillin, cefaclor (CECLOR), levofloxacin (LEVAQUIN), erythromycin ethylsuccinate (EES), Steroids, Sulfa, cefixime (CITROEN), Cephalosporins, montelukast sodium (SINGULAIR), paracetamol (TYLENOL), ibuprofen (MOTRIN), citrus. Concomitant drugs included estradiol (YUVAFEM), estradiol, Vitamin D3, calcium, magnesium. Historical vaccine included 1st dose of BNT162B2 (lot EN 6207) on 10Mar2021 at 12:00 PM, 2nd dose of BNT162B2 (lot ER 8737) on 31Mar2021 at 12:00 PM, both at right arm for Covid-19 Immunization at the age of 64 years old. The patient reported that on 11Oct2021 at 10pm after the injection stabbing pain across lower back-area of sacrum, across upper back-area between the shoulders, bilateral feet, ankles, hands & ear dum area. She felt like a voodoo doll being stabbed at and flopping back & forth like a fish out of water moaning & groaning. This level of intensity lasted 24 hours. Since that, at night, lying in bed-trying to go to sleep the pricking, zap/jab feeling starts in primarily the bilateral feet and ankles neuropathy (she was not diabetic) until she can take enough over the counter meds to fall asleep. During the day just occasional zaps and jabs. Another problem during the first 7 days the amount of sleep had decreased to no sleep & therefore no relief from the zaps/jabs. She finally had to consume alcohol x2 nights and smoke marijuana the last 2 nights. The marijuana seems to be the trick finally the number of daytime hours has been reduced to just a few and it also put her to sleep and enabled her sleep. The events resulted in doctor office visit. The outcome of the events was resolving.
The evening of vaccine patient started feeling extremely weak, progressed to feeling dizzy, lightheaded, and faint. Patient had difficulty swallowing + Breathing. She felt a little better the next day. She felt fine 10/8/10.
I experienced excessive bleeding during my menstrual cycle, increased headache, weight gain and sadness & depression. My lymph nodes on the left side of my neck were swollen and lymph nodes under my left axillary tender to touch (difficult to apply deodorant). I contacted my GYN and was advised that these are common symptoms that people are experiencing. As of today, I still have skin discoloration at the injection site.
pt recv flu & pneumococcal vax combined & given in one inj & exp soreness @ site;
Starting at 8:00PM on 3/18/09 Temp of 101 degrees.  3/19/09 Temp 102.9.  To use Tylenol or Motrin.  To take to ER if lethargic or not doing well.
Information has been received from a physician concerning a 14 year old female patient who in July 2008, was vaccinated with a 0.5ml first dose of GARDASIL (Lot # not reported), IM. The physician stated that the patient has started receiving GARDASIL two years ago in approximately 2008 but never completed it because she started getting severe headaches, possibly migraines and vomiting. The patient was scheduled for gastrointestinal (G.I), and neurology exams (No results reported). It was reported that the patient received unspecified treatment. At the time of the report, the patient had not recovered. The patient sought unspecified medical attention. Additional information has been requested.
hives all over body, extreme exhaustion, bad h/a, aches-w/in a few hr p/vax sx lasted 2 1/2 days;DPH taken for hives;advil taken for aches & h/a;sx worse by end of next day p/shot;swelling of lt arm;
Information has been received from a Doctor of Pharmacy an 82 year old female patient who on 06-MAY-2011, was vaccinated subcutaneously in the left arm with a dose of ZOSTAVAX (Merck) (lot# 670039/0358AA; expiration date: 09-JUN-2012). The pharmacist reported that on 07-MAY-2011, the patient developed a hot injection site rash that spread to her elbow. The pharmacist reported the patient's rash resolved on an unspecified date, without treatment. The patient sought medical attention as she was seen in the doctor's office. Additional information has been requested.
At the first 5 minutes, I couldn't hear from my left ear and then my face was swollen and it was numb. I talked to the nurse told me not to worry and to take a Claritin and go home. After 30 minutes at home, I was feeling nausea and I had migraines. After few days the doctors sent me on the emergency for a scan on my head. I still have migraines and feel nausea. Sometimes, I cannot even walk on the corner of my house. In the emergency they gave me some medicines and I was feeling better but only for one day. I wish that the nurse would send me on the hospital right away to receive a treatment and not at home.
quite sick; slept for 12 hours; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (quite sick) and SOMNOLENCE (slept for 12 hours) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (quite sick) and SOMNOLENCE (slept for 12 hours). At the time of the report, ILLNESS (quite sick) and SOMNOLENCE (slept for 12 hours) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.
ACCORDING TO FAMILY, ABOUT 15-20 MINUTES AFTER RECEIVED INFLUENZA IMMUNZATION ON 10/22/08, DEVELOPED RASH.  WENT TO ER AND WAS TOLD ALLERGIC REACTION AND PRESCRIBED BENADRYL, PREDNISONE.  WHEN SEEN IN FOLLOWUP ON 10/23/08 HAD SPLOTCHY, BLANCHING ERYTHEMATOUS RASH ON FACE, CHEST, UPPER EXTREMITIES.
Headache, fever, intense burning sensation in both arms, very painful to move, severe body aches, vaccination site sore to the touch.
Pt. states that after receiving the 2nd dose of Moderna 09/02/2021, started experiencing symptoms 09/15/2021 of headaches, weakness, fatigue, nausea, and heavy menstrual. Has used 2 boxes of pads to prevent leaking and clotting thick menstrual.
Persistent generalized upper arm soreness lasting greater than 16 days with mild limitation to range of motion.
I95.9 HYPOTENSION 4/22/2023 HYPONATREMIA J96.10 CHRONIC RESPIRATORY FAILURE 1/17/2023 HYPONATREMIA I95.9 HYPOTENSION 4/22/2023 BARRETTS ESOPHAGUS J96.10 CHRONIC RESPIRATORY FAILURE 1/17/2023 BARRETTS ESOPHAGUS
p/vax pt devel fever; next day vomiting; cont to ER; yellow color to skin; liver enzymes elevated; WBC elevated; given Rocephin IM; nausea;APAP for fever; to have repeat liver enzymes & liver ultrasound 8/18 & 8/19
This spontaneous report as received from a licensed vocational nurse refers to multiple unspecified patients of unknown age and gender. On unknown dates, the patients were vaccinated with improperly stored doses of ROTATEQ (lot # L026741 exp date 18-MAY-2017, L022446 exp date 14-FEB-2017; L026740 exp date 16-APR-2017 and lot # L027726 exp date 10-MAY-2017)(dose not reported) orally. No adverse effects were reported. This is one of several reports  received from the same source. Additional information has been requested.
patient passed out,  woke up less than 1 minute later and was pale and nauseous
Two weeks after the vaccine, I started to have stomach cramps. I also had loose stools. I noticed blood in the stools and I went to urgent care on 01/20/2021. Tests confirmed a lower bowel inflammation which I had never had an issue with before. I was advised to eat crackers and water for four days. The bowel issues lasted for two weeks. I was also experiencing tiredness even when I woke up in the morning which lasted for about two months. I have not had any more problems since that time.
Localized swelling,  redness and itching 6 cm in diameter at injection site. it developed about 7 days after the injection
The client and her mother were in the office, so patient could get Hepatitis A and Meningococcal immunizations. Following the immunizations and follow-up discussion about the next Hepatitis A, they went to the waiting area. Patient got up and was walking back to the immunization room, 9:35 AM. I met her in the hall and she asked for a cold pack. I asked what she needed it for and before she could answer, she started to go down. I held her and her mother came and held her from the back and we lowered her to the floor. By the time she was on the floor, she looked at us and asked if she had fainted. She had no complaints. There was no injury. At 9:40 AM her blood pressure was 98/62 and pulse was 68. She was then alert and talkative. We let her lay on the floor until she was comfortable to sit up and then stand up. She then went and sat in the waiting area and drank some water and at 9:55 AM, she and her mother left the office.
Dizziness, Headache, NauseaVomiting, chills Narrative:
died from Covid 5 days after diagnosis; died from Covid 5 days after diagnosis; This is a spontaneous report from a non-contactable consumer or other non hcp. A 35-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose, dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. A healthy patient died from Covid 5 days after diagnosis even though she had both Pfizer vaccine shots. Event took place after use of product. The outcome of the events was fatal. The patient died on an unspecified date. It was not reported if an autopsy was performed.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: died from Covid 5 days after diagnosis; died from Covid 5 days after diagnosis
Starting about 5 minutes after the shot, I started getting a little bit lightheaded. I left the pharmacy and went home. I then started to feel numbness all over the right side of my body, blurred vision and dizziness. I decided to rest. It?s been 4 hours now since I got the vaccine. I?m still lightheaded and have numbness on my right side, but it is getting better.
p/recv vax pt left arm swelling; deltoid region to elbow, redness induration; no pain; no tenderness;
Initial information has been received from a nurse and follow up information from a medical assistant who reported that a 49 year old female was on 20-APR-2009 was vaccinated with a dose of PNEUMOVAX 23 (lot #662667/1435X), 0.5 ml. On approximately 20-APR-2009 the patient experienced pain, redness, warmth on the injection site and the injection site was tender to the touch. She sought unspecified medical attention. The medical assistant reported that she did not know the patient's status as she had not kept her appointment. Follow up information received on 01-JUN-2009 from a medical assistant stated that a manager had no illness at the time of vaccination, and on 21-APR-2009 (not 20-APR-2009 as previously reported) at 12:22 was vaccinated with the first dose of PNEUMOVAX 23 (lot 662667/1435X), intramuscularly into the left deltoid. On the same date the patient developed severe swelling, warmth and erythema (patient reported). No laboratories studies performed. In follow up, the medical assistant reported that the severe swelling, warmth and erythema resulted in persistent or significant disability/incapacity. The patient's outcome was unknown. A standard lot check investigation was performed. All in process quality checks for the lot number in question were satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Additional information has been requested.
patient should have gotten the pediatric pfizer covid-19 vaccine, but the incorrect vial was selected so patient received a higher dose than he should have. the adult vial was used, but mixed according to the pediatric vial instructions (1.3ml diluent) and 0.2ml vaccine was given. mom reports sore arm at this time, but patient does have a history of cardiac illness, so they will follow up with pediatrician and cardiologist.
Blood clot in my left forearm. I first noticed it on 4/20 around 7pm. There was a bump (the size of a dime) and small bruise. Overnight the bump got a bit smaller and the bruise expanded. Over the next several days the bump kept diminishing. The bruise remained about the same size and kept getting darker. It?s been one week now and the bump is very tiny (size of a small pea), and the bruise is incredibly dark, but showing more of a healing process color.
Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021; Patient Received vaccine past 30-days Expiry date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient Received vaccine past 30-days Expiry date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2022 at 9:45 AM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Apr-2022 at 9:45 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient Received vaccine past 30-days Expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient Received vaccine past 30-days Expiry date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter. Vaccine administration time 09:45:19   This case was linked to MOD-2022-542869 (Patient Link).
Within 2-3 hours of receiving the second dose, I developed a subconjunctival hemorrhage on the left side of my left eye (covering the entire left side of my eye). No doctor was seen as a result. It continues to resolve (it has not cleared yet).
rash took place after use of product  that covered patient bicep; This is a spontaneous report from a contactable Pharmacist via sales representative. This Pharmacist reported similar events for 2 patients. This is first of 2 reports.   A female patient of unspecified age received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date at single dose for immunisation. The relevant medical history and concomitant medications were not reported. The Pharmacist had questions about reactions to pneumococcal 13-val conj vac (dipht crm197 protein) that included a rash that covered patient bicep. The pharmacist wanted to know if this had been happening more lately or if something was different because something similar occurred to another patient of hers. Event took place after use of product. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2020399755 same reporter/drug, similar event, different patient.
Patient is reporting ringing in his ears that lasted for about 14 days after he received vaccination.
I get vertigo every time I lay down for bed, wake up or change head positions. To date, it has become less intense but is still present every day.
4/12 Fussy Behavior exhibited out of character, continues as of 4/27 4/22 rash on right calf 4/23 rash on neck, back, and stomach 4/24 rash continued covering all body, head, hands, legs, bottom... small red raised bumps.  extreme fussiness 4/27 rash has begun to subside
Her left arm swelled > 5 inches around the site of injection and was very red. Face was flushed with fever and child for almost 24 hours. Redness still > 4 inches around site still on 12/8/13.
Approx. 1 1/2 hours, post vax, mother called and stated that child's face was tightening and child was shaky, intermittently, breathing was fine, color pink. Child did not feel warm; however, she felt "clammy". Instructed mother to take child to closest ER for further evaluation.
Information was received on 15-FEB-2019 by a lawyer regarding a case in litigation, concerning a male patient, history not provided. On 07-MAR-2017 the patient was prescribed and administered ZOSTAVAX by a health care provider at a medical office. On 17-MAR-2017 the patient was treated by a health care provider at a hospital. Outcome was not provided. Additional information has been requested.
This case was reported by physician and described the occurrence of vomiting in a 52 year old female patient who received hepatitis A inactivated and hepatitis B recombinant vaccine (Twinrix).  This case was initially reported by a nurse.  Follow up was received from the primary care physician.  On 09/16/2004, the patient received the first dose of Twinrix in the right arm (lot HAB239A4).  At an unspecified time following the administration of Twinrix, on 09/16/2004, the patient experienced nausea, vomiting, headache, a low grade fever, chills, fatigue and dizziness.  On 09/18/2004, the events continued and the patient also experienced slurred speech, personality changes, tremors, tingling in the right side of her face when she turns her neck an certain way, photophobia, muscle weakness, and myalgia.  The patient was seen at the primary care physician's office on 09/21/2004.  Tests performed on 09/21/2004, were negative for west nile virus, and were normal for complete blood count, mean corpuscular volume and erythrocyte sedimentation rate.  A repeat test performed approximately 3 weeks later, on an unspecified date in October 2004 were normal for complete blood count, mean corpuscular volume and thyroid stimulating hormone.  The reporting physician stated there was, no additional evidence of a viral infection.  The immunization series with Twinrix was discontinued.  The events were ongoing at the time of follow up.  The physician considered the events to possibly be related to vaccination with Twinrix.